Folate-receptor-α antibody-drug conjugate
Mirvetuximab soravtansine (Specialist drug)
Brand names: Elahere
Adult dose
Dose: Specialist initiation only — refer to BNF/SmPC
Route: IV
Frequency: every 3 weeks
Clinical pearls
- Folate-receptor-α-positive platinum-resistant ovarian cancer; specialist oncology
- Mandatory ophthalmic exam before each dose
Contraindications
- Hypersensitivity
Side effects
- Ocular toxicity (keratopathy, blurred vision)
- Pneumonitis
- Peripheral neuropathy
- Cytopenias
Interactions
- Live vaccines
Monitoring
- Ophthalmic
- FBC
- Pulmonary symptoms
- Neurological exam
Reference: BNF; SmPC; https://bnf.nice.org.uk/drugs/mirvetuximab-soravtansine-specialist-drug/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Tisdale Risk Score for QT Prolongation · Arrhythmia
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy